CHF533.00
0.26% day before yesterday
SIX Swiss Exchange, Dec 23, 05:31 pm CET
ISIN
CH0013841017
Symbol
LONN

Lonza Stock price

CHF533.00
-1.80 0.34% 1M
-28.00 4.99% 6M
-2.80 0.52% YTD
+0.60 0.11% 1Y
+79.10 17.43% 3Y
-21.00 3.79% 5Y
+385.44 261.21% 10Y
+460.75 637.71% 20Y
SIX Swiss Exchange, Closing price Tue, Dec 23 2025
+1.40 0.26%

New AI Insights on Lonza Insights AI Insights on Lonza

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
CHF36.4b
Enterprise Value
CHF40.1b
Net debt
CHF3.7b
Cash
CHF907.0m
Shares outstanding
68.6m
Valuation (TTM | estimate)
P/E
51.1 | 31.8
P/S
5.1 | 4.7
EV/Sales
5.7 | 5.2
EV/FCF
negative
P/B
4.2
Dividends
DPS
CHF4.00
Yield 1Y | 5Y
0.8% | 0.7%
Growth 1Y | 5Y
0.0% | 7.8%
Payout 1Y | 3Y
44.8% | 33.7%
Increased
0 Years
Financials (TTM | estimate)
Revenue
CHF7.1b | CHF7.7b
EBITDA
- | CHF2.3b
EBIT
CHF1.0b | CHF1.5b
Net Income
CHF733.0m | CHF1.2b
Free Cash Flow
CHF-296.0m
Growth (TTM | estimate)
Revenue
5.9% | 17.4%
EBITDA
- | 74.3%
EBIT
19.8% | 30.7%
Net Income
27.9% | 81.2%
Free Cash Flow
-492.0%
Margin (TTM | estimate)
Gross
32.9%
EBITDA
- | 29.2%
EBIT
14.8%
Net
10.3% | 14.9%
Free Cash Flow
-4.2%
Financial Health
Equity Ratio
47.3%
Return on Equity
6.8%
ROCE
6.7%
ROIC
-
Debt/Equity
0.5
More
EPS
CHF10.4
FCF per Share
CHF-4.3
Short interest
-
Employees
19k
Rev per Employee
CHF340.0k
Show more

Create a Free Account to create an Lonza alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Lonza Stock Analysis

Unlock Scores for Free

Analyst Opinions

30 Analysts have issued a Lonza forecast:

26x Buy
87%
4x Hold
13%

Analyst Opinions

30 Analysts have issued a Lonza forecast:

Buy
87%
Hold
13%

Financial data from Lonza

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
7,093 7,093
6% 6%
100%
- Direct Costs 4,757 4,757
0% 0%
67%
2,336 2,336
19% 19%
33%
- Selling and Administrative Expenses - -
-
-
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 1,047 1,047
20% 20%
15%
Net Profit 733 733
28% 28%
10%

In millions CHF.

Don't miss a Thing! We will send you all news about Lonza directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Lonza Stock News

AD HOC NEWS
3 months ago
Lonza Group AG / CH0013841017
More Lonza News

Company Profile

Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products. It operates through the following segments: Pharma & Biotech; Specialty Ingredients; and Corporate. The Pharma & Biotech segment comprises development and manufacture of customized active pharmaceutical ingredients and biopharmaceuticals as well as formulation services and delivery systems. The Specialty Ingredients segment consists of two divisions, consumer health and consumer resources and protection. The Corporate segment includes corporate functions, such as finance and accounting, legal, communication, information technology, and human resources. The company was founded in 1897 and is headquartered in Basel, Switzerland.

Head office Switzerland
CEO Dr. Wienand
Employees 19,299
Founded 1897
Website www.lonza.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today